Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8237774 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 7 Pages |
Abstract
Adverse effects with long-course ADT on persistent GU morbidity were observed in this study. Additional investigation is needed to identify suitable ADT administration according to risk groups, but long-course ADT should not be adopted for non-high-risk prostate cancer patients to reduce the GU toxicity rate with C-ion RT.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Hitoshi M.D., Ph.D., Hiroshi M.D., Ph.D., Tadashi M.D., Ph.D., Naoki M.D., Takeshi M.D., Ph.D., Jun-Estu M.D., Ph.D., Koichiro M.D., Ph.D., Hiroyoshi M.D., Ph.D., Jun M.D., Ph.D., Takashi M.D., Ph.D., Hirohiko M.D., Ph.D.,